BioFlorida Celebration of Biotechnology Shines a Light on the Future of the City of Alachua
BioFlorida held its Celebration of Biotechnology today behind the new AGTC buildings on US Hwy 441 in Alachua, just across from Progress Park, highlighting the future plans for the area that will be known as the Progress District. The Celebration was the first since 2019.
Dialectic Therapeutics Receives FDA Clearance of IND Application for for Its Lead Product Candidate To Treat Cancer
UF startup Dialectic Therapeutics, Inc., a Texas-based biotechnology company focused on creating innovative new technologies to treat cancer, announced that the U.S. Food and Drug Administration (FDA) has concluded that Dialectic may proceed with its clinical investigation for its lead product candidate, DT2216, a unique compound built using its proprietary and novel Antiapoptotic Protein Targeted Degradation (APTaD) technology.
